2nd Quarter - Report
BROWN RUDNICK LLP for AMNEAL PHARMACEUTICALS
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2051 - The FAST Generics Act; H.R. 2212 & S.974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT DENNIS FOREMAN New | The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005) |
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
| HENRY W MENN | CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.